Idoroenyi Amanam, MD

Idoroenyi Amanam, MD is an assistant professor in the Division of Leukemia at City of Hope. He earned his medical degree from Meharry Medical College and completed residency at St. Mary-UCLA, where he was Intern, Resident, and Chief Resident. He trained in hematology/oncology at City of Hope/UCLA-Harbor and completed a fellowship in Hematopoietic Cell Transplantation and Cellular Therapy. His research focuses on leukemia, stem cell transplants, and myeloproliferative neoplasms. He is multilingual and deeply values compassionate patient care.

Articles by Idoroenyi Amanam, MD

Naval Daver, MDChronic Myeloid Leukemia | June 5, 2025
Expert insights from a HemOnc Pulse Live! session offer a compelling look at where CML and MPN care is headed.
View More
Pankit Vachhani, MDMyelofibrosis | May 12, 2025
Experts discuss patient-centered approaches and novel therapies reshaping MF treatment in a roundtable.
Prithviraj Bose, MDMyelofibrosis | May 12, 2025
Experts explore anemia therapies, JAK inhibitors, and transplant innovations shaping the promising future of MF care.
Naseema Gangat, MBBSMyelofibrosis | May 12, 2025
Experts discuss molecular insights into MF, highlighting mutations, risk assessment, and evolving therapeutic approaches.
Prithviraj Bose, MDMyelofibrosis | May 12, 2025
Experts discuss current treatments and ongoing research in myelofibrosis, highlighting new therapies and clinical trials.
Idoroenyi Amanam, MDMyelofibrosis | May 12, 2025
Experts discuss CALR-targeting therapies, symptom assessment, and the future of myelofibrosis treatment and regulation.